Etid klinik pou Menenjyom nan Maryland
5 etid pou Menenjyom ap chèche patisipan nan sit nan Maryland.
Vil nan Maryland
Tèks ofisyèl etid la (Anglè)
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT02523014Natural History Study of Patients With Neurofibromatosis Type 2
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 8 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT00598351Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
- Johns Hopkins Hospital, Baltimore
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT04374305Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
- Johns Hopkins, Baltimore
Ap rekriteFaz 1/2
Laj 18 a 90 · Tout sèks · Mizajou May 14, 2026 · NCT05636618Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
- National Institutes of Health, Bethesda
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT04541082Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.